China Pharma HoldingSTU:XQJ 26 Median PS Value is €21.77 as of Jul. 11, 2026, which is 100% below its 10-year median of 1.24. GuruFocus rates STU:XQJ with a GF Score™ of 26/100 and a GF Value™ of €10.05. The stock has 3 warning signs investors should review. Among 544 Drug Manufacturers companies, China Pharma Holding ranks worse than 72.43% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for China Pharma Holding's Median PS Value or its related term are showing as below:
STU:XQJ'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.21 Med: 1.24 Max: 5.2
Current: 1.23
During the past 13 years, the highest Price to Median PS Value of China Pharma Holding was 5.20. The lowest was 0.21. And the median was 1.24.
STU:XQJ's Price-to-Median-PS-Value is ranked worse than 72.43% of 544
companies
in the Drug Manufacturers industry
Industry Median: 0.86
vs STU:XQJ: 1.23
China Pharma Holding (STU:XQJ) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
China Pharma Holding's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
26.80
/
21.77
=
1.23
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Pharma Holding Median PS Value Related Terms
China Pharma Holding Median PS Value Historical Data
* Premium members only.
The historical data trend for China Pharma Holding's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:XQJ vs TXMD, RMTI, AYTU: Median PS Value Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, China Pharma Holding's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Pharma Holding Price-to-Median-PS-Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, China Pharma Holding's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where China Pharma Holding's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 40.3896.
China Pharma Holding's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.539.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Pharma Holding (STU:XQJ) has a Median PS Value of €21.77 as of Jul. 11, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on China Pharma Holding and its competitors. This is 1656% above median its historical median of 1.24. Over the past decade, China Pharma Holding's Median PS Value has ranged from 0.21 to 5.20. According to the industry distribution chart, China Pharma Holding ranks #394 out of 544 companies in the Drug Manufacturers industry, placing it in the top 72.4%.
Is China Pharma Holding's Median PS Value too high?
China Pharma Holding's current Median PS Value of €21.77 is 1656% above median its 10-year median of 1.24. Over the past 10 years, this metric has ranged from a low of 0.21 to a high of 5.20. Based on the distribution chart, China Pharma Holding ranks #394 out of 544 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, China Pharma Holding has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does China Pharma Holding's Median PS Value compare to TXMD and RMTI?
According to the Drug Manufacturers industry distribution chart, China Pharma Holding ranks #394 out of 544 companies for Median PS Value. This places China Pharma Holding in the lower half of its industry. The industry median Median PS Value is 0.86. Historically, China Pharma Holding's own Median PS Value has ranged from 0.21 to 5.20 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Drug Manufacturers company?
The median Median PS Value among Drug Manufacturers companies is 0.86, based on 544 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on China Pharma Holding and its competitors. For the Drug Manufacturers industry, the median Median PS Value is 0.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Pharma Holding's current Median PS Value is €21.77, which is 1656% above median its own 10-year median of 1.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Pharma Holding stock overvalued right now?
China Pharma Holding (STU:XQJ) has a current Median PS Value of €21.77. The stock's GF Value™ is €10.05, compared to a current price of €26.80 — trading 166.7% above its estimated fair value. The current Median PS Value is €21.77, which is 1656% above median its 10-year median of 1.24. China Pharma Holding's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For China Pharma Holding (STU:XQJ), the current Median PS Value is €21.77 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Pharma Holding (STU:XQJ) Overvalued in 2026?
Based on GuruFocus' analysis, China Pharma Holding stock appears to be overvalued.
The current stock price of €26.80 is trading 166.7% above its estimated GF Value™ of €10.05.
Key valuation signals for STU:XQJ:
Median PS Value: €21.77 (1656% above median its 10-year median of 1.24)
GF Value™: €10.05 vs. price of €26.80 (166.7% above fair value)
No single metric tells the full story. See the STU:XQJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.
26GF Score
Get the complete analysis for STU:XQJ
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:XQJ has been successfully added to your 
